AVAX Technologies, Inc. (AVXT)

0.0001 0.0000 (0.00%) 市場開市。 截至 03:50PM EDT。

AVAX Technologies, Inc.

2000 Hamilton Street
Suite 204
Philadelphia, PA 19130
United States
215-241-9760
https://www.avax-tech.com

版塊: Healthcare
行業: Biotechnology
全職員工: 9

描述

AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.

公司管治

截至 無 止，AVAX Technologies, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。